Literature DB >> 31119770

Adjusted restricted mean survival times in observational studies.

Sarah C Conner1,2, Lisa M Sullivan1, Emelia J Benjamin2,3,4, Michael P LaValley1, Sandro Galea3, Ludovic Trinquart1,2.   

Abstract

In observational studies with censored data, exposure-outcome associations are commonly measured with adjusted hazard ratios from multivariable Cox proportional hazards models. The difference in restricted mean survival times (RMSTs) up to a pre-specified time point is an alternative measure that offers a clinically meaningful interpretation. Several regression-based methods exist to estimate an adjusted difference in RMSTs, but they digress from the model-free method of taking the area under the survival function. We derive the adjusted RMST by integrating an adjusted Kaplan-Meier estimator with inverse probability weighting (IPW). The adjusted difference in RMSTs is the area between the two IPW-adjusted survival functions. In a Monte Carlo-type simulation study, we demonstrate that the proposed estimator performs as well as two regression-based approaches: the ANCOVA-type method of Tian et al and the pseudo-observation method of Andersen et al. We illustrate the methods by reexamining the association between total cholesterol and the 10-year risk of coronary heart disease in the Framingham Heart Study.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  inverse probability weighting; observational studies; propensity score; restricted mean survival time; survival analysis; time-to-event data

Mesh:

Year:  2019        PMID: 31119770      PMCID: PMC7534830          DOI: 10.1002/sim.8206

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  35 in total

1.  Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects.

Authors:  Patrick Royston; Mahesh K B Parmar
Journal:  Stat Med       Date:  2002-08-15       Impact factor: 2.373

2.  SAS and R functions to compute pseudo-values for censored data regression.

Authors:  John P Klein; Mette Gerster; Per Kragh Andersen; Sergey Tarima; Maja Pohar Perme
Journal:  Comput Methods Programs Biomed       Date:  2008-01-15       Impact factor: 5.428

3.  Commentary: Some Thoughts on Consequential Epidemiology and Causal Architecture.

Authors:  Charles Poole
Journal:  Epidemiology       Date:  2017-01       Impact factor: 4.822

Review 4.  Hazard ratios in cancer clinical trials--a primer.

Authors:  Krastan B Blagoev; Julia Wilkerson; Tito Fojo
Journal:  Nat Rev Clin Oncol       Date:  2012-01-31       Impact factor: 66.675

5.  Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies.

Authors:  Hajime Uno; Janet Wittes; Haoda Fu; Scott D Solomon; Brian Claggett; Lu Tian; Tianxi Cai; Marc A Pfeffer; Scott R Evans; Lee-Jen Wei
Journal:  Ann Intern Med       Date:  2015-07-21       Impact factor: 25.391

Review 6.  Comparison of Treatment Effects Measured by the Hazard Ratio and by the Ratio of Restricted Mean Survival Times in Oncology Randomized Controlled Trials.

Authors:  Ludovic Trinquart; Justine Jacot; Sarah C Conner; Raphaël Porcher
Journal:  J Clin Oncol       Date:  2016-02-16       Impact factor: 44.544

7.  Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome.

Authors:  Patrick Royston; Mahesh K B Parmar
Journal:  BMC Med Res Methodol       Date:  2013-12-07       Impact factor: 4.615

8.  Using simulation studies to evaluate statistical methods.

Authors:  Tim P Morris; Ian R White; Michael J Crowther
Journal:  Stat Med       Date:  2019-01-16       Impact factor: 2.497

9.  Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis.

Authors:  Peter C Austin
Journal:  Stat Med       Date:  2016-08-22       Impact factor: 2.373

10.  Interpretation of time-to-event outcomes in randomized trials: an online randomized experiment.

Authors:  I R Weir; G D Marshall; J I Schneider; J A Sherer; E M Lord; B Gyawali; M K Paasche-Orlow; E J Benjamin; L Trinquart
Journal:  Ann Oncol       Date:  2019-01-01       Impact factor: 32.976

View more
  10 in total

1.  Stratified Restricted Mean Survival Time Model for Marginal Causal Effect in Observational Survival Data.

Authors:  Ai Ni; Zihan Lin; Bo Lu
Journal:  Ann Epidemiol       Date:  2021-10-04       Impact factor: 3.797

2.  Restricted mean survival time regression model with time-dependent covariates.

Authors:  Chengfeng Zhang; Baoyi Huang; Hongji Wu; Hao Yuan; Yawen Hou; Zheng Chen
Journal:  Stat Med       Date:  2022-06-23       Impact factor: 2.497

3.  Life-Years Lost After Newly Diagnosed Atrial Fibrillation in Patients with Heart Failure.

Authors:  Nicklas Vinter; Pia Cordsen; Gregory Y H Lip; Emelia J Benjamin; Søren Paaske Johnsen; Lars Frost; Ludovic Trinquart
Journal:  Clin Epidemiol       Date:  2022-05-31       Impact factor: 5.814

4.  Veridical Causal Inference using Propensity Score Methods for Comparative Effectiveness Research with Medical Claims.

Authors:  Ryan D Ross; Xu Shi; Megan E V Caram; Pheobe A Tsao; Paul Lin; Amy Bohnert; Min Zhang; Bhramar Mukherjee
Journal:  Health Serv Outcomes Res Methodol       Date:  2020-10-20

5.  Novel Risk Modeling Approach of Atrial Fibrillation With Restricted Mean Survival Times: Application in the Framingham Heart Study Community-Based Cohort.

Authors:  Laila Staerk; Sarah R Preis; Honghuang Lin; Juan P Casas; Kathryn Lunetta; Lu-Chen Weng; Christopher D Anderson; Patrick T Ellinor; Steven A Lubitz; Emelia J Benjamin; Ludovic Trinquart
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-03-31

6.  Counterfactual mediation analysis in the multistate model framework for surrogate and clinical time-to-event outcomes in randomized controlled trials.

Authors:  Isabelle R Weir; Jennifer R Rider; Ludovic Trinquart
Journal:  Pharm Stat       Date:  2021-08-04       Impact factor: 1.894

7.  Treatment Effect Measures for Culture Conversion Endpoints in Phase IIb Tuberculosis Treatment Trials.

Authors:  Isabelle R Weir; Sean Wasserman
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

8.  Does time heal all wounds? Life course associations between child welfare involvement and mortality in prospective cohorts from Sweden and Britain.

Authors:  Josephine Jackisch; George B Ploubidis; Dawid Gondek
Journal:  SSM Popul Health       Date:  2021-03-11

9.  Continuous renal replacement therapy versus intermittent hemodialysis as first modality for renal replacement therapy in severe acute kidney injury: a secondary analysis of AKIKI and IDEAL-ICU studies.

Authors:  Jean-Pierre Quenot; Didier Dreyfuss; Stéphane Gaudry; François Grolleau; Saber Barbar; Laurent Martin-Lefevre; Bertrand Pons; Éric Boulet; Alexandre Boyer; Guillaume Chevrel; Florent Montini; Julien Bohe; Julio Badie; Jean-Philippe Rigaud; Christophe Vinsonneau; Raphaël Porcher
Journal:  Crit Care       Date:  2022-04-04       Impact factor: 9.097

10.  Estimation and modeling of the restricted mean time lost in the presence of competing risks.

Authors:  Sarah C Conner; Ludovic Trinquart
Journal:  Stat Med       Date:  2021-02-10       Impact factor: 2.373

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.